Learn / RLAY
NASDAQ: RLAY
Relay Therapeutics (RLAY) stock, explained like you're 5
Relay Therapeutics trades on the Nasdaq under the ticker RLAY. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 3.9 billion dollars.
- Ticker
- RLAY
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 3.9 billion dollars
Is Relay Therapeutics a small, medium or large cap company?
No. Relay Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.9 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Relay Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RLAY stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Why Is RLAY Stock Rising Today? (Stocktwits)
- RLAY Nov 2026 18.000 call (RLAY261120C00018000) interactive stock chart (Yahoo Finance UK)
- RLAY Stock Technical Analysis (Pluang)
- Relay: The Recent Market Excitement Ignores The Reality Of Clinical Risks And Patent Cliffs (Seeking Alpha)
- Relay Therapeutics (RLAY) Stock May Be Fully Valued After A 7x Run (Simply Wall Street)
Follow RLAY in your daily brief
Each trading day at 5 PM ET we post what happened to Relay Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RLAY
Questions about Relay Therapeutics stock
What does Relay Therapeutics do?
Relay Therapeutics trades on the Nasdaq under the ticker RLAY. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 3.9 billion dollars.
What is the ticker symbol for Relay Therapeutics?
Relay Therapeutics trades under the ticker RLAY on the Nasdaq.
What is Relay Therapeutics's market cap?
Relay Therapeutics is a mid cap stock with a market cap of about 3.9 billion dollars.
How does Relay Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RLAY stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RLAY stock every day?
Add RLAY to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.